Solvin Cold Syrup is frequently recommended for children to alleviate typical symptoms associated with the common cold, such as sore throat, nasal congestion, coughing, sneezing, watery eyes, body aches, and fever. This syrup can be administered orally, and it may be given with or without meals. Due to the sensitivity of children’s stomachs, if they experience any stomach discomfort after taking the medicine, it is advisable to administer it with food. It is essential to follow the dosing instructions provided by your child’s physician, which are tailored according to their specific symptoms. Consistency is key; giving Solvin Cold Syrup at a designated time each day helps to incorporate it into your child’s routine, making it easier to remember. If your child vomits within 30 minutes of taking the dosage, you may repeat that dose, but do not give the same dose again if it is close to the time for the next scheduled dose. Typically, children may start to feel relief within a week of consistent use, but it is crucial to complete the entire course of medication as directed by the doctor, as stopping suddenly could exacerbate their condition. While taking this syrup, some minor and temporary side effects may occur, including vomiting, diarrhea, nausea, dizziness, rashes, and headaches. These side effects generally resolve as the body adjusts to the medication. If they persist or become troublesome, it is important to contact your child’s healthcare provider promptly. Always ensure your child’s medical history is disclosed to the doctor, including any ongoing medications or allergies, as well as any history of heart issues, blood disorders, birth defects, respiratory issues, skin conditions, liver problems, or kidney diseases. This information is vital for appropriate dose adjustments and overall treatment planning.
-15%

SOLVIN COLD (Chlorpheniramine Maleate (1mg) + Paracetamol (125mg) + Phenylephrine (2.5mg))
Original price was: ₹80.10.₹68.30Current price is: ₹68.30.
Add to cart
Buy Now



Reviews
There are no reviews yet.